The impact of early direct-contact experiences on reducing mental health stigma among student pharmacists: A pilot study [0.03%]
早期直接接触经历对降低药学生心理健康污名的影响：初步研究
Amber R Tran,Saumyaa A Patel,Lindsey J Loera et al.
Amber R Tran et al.
Introduction: Mental health-related stigma is a barrier to treatment and recovery for serious mental illnesses (SMIs). Educational training programs demonstrate positive changes in health professional students' attitudes ...
Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review [0.03%]
通过临床医生调查和病历审查探索多巴胺转运蛋白2抑制剂治疗患者中晚期运动障碍的真实世界症状影响及健康状况改善情况
Jonathan M Meyer,Craig Chepke,Rimal B Bera et al.
Jonathan M Meyer et al.
Introduction: Two vesicular monoamine transporter 2 (VMAT2) inhibitors are approved in the United States (US) for the treatment of tardive dyskinesia (TD). There is a paucity of information on the impact of VMAT2 inhibito...
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports [0.03%]
药物治疗慢性失眠的疗效和安全性：临床指南和病例报告的回顾
Alejandro Del Rio Verduzco,Ahva Salari,Parna Haghparast
Alejandro Del Rio Verduzco
Introduction: Chronic insomnia affects 5% to 10% of the US population, increasing the demand for treatment options and the corresponding research to prove their validity.1 This review compares recommendations from 3 clini...
Predictors of persistence and adherence to deutetrabenazine among patients with Huntington disease or tardive dyskinesia [0.03%]
亨廷顿病或迟发性运动障碍患者持续并坚持使用氘苯吗啉酯的影响因素预测
Daniel O Claassen,Rajeev Ayyagari,Viviana García-Horton et al.
Daniel O Claassen et al.
Introduction: Deutetrabenazine is approved for treatment of Huntington disease (HD)-related chorea and tardive dyskinesia (TD) in adults. Factors associated with deutetrabenazine persistence and adherence are not well und...
Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report [0.03%]
鼻内酮胺作为治疗长期COVID的精神病并发症的治疗方法：一项病例报告
Kaitlyn Baldwin,Annabelle Wanson,Lee-Anne Gilecki et al.
Kaitlyn Baldwin et al.
Background: Neuropsychiatric symptoms associated with long COVID are a growing concern. A proposed pathophysiology is increased inflammatory mediators. There is evidence that typical serotonergic antidepressants have limi...
Cambrey Nguyen,Karen E Moeller,Michael McGuire et al.
Cambrey Nguyen et al.
Introduction: The legalization of cannabidiol (CBD) across the United States, in varying degrees, has made CBD easily accessible to consumers for complementary and medical purposes. However, there is a paucity of scientif...
Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital [0.03%]
持证精神药剂师对急性精神病医院尿路感染抗生素合理使用改善的影响
Mohammad Adam Hamad,Andrew Williams,Jamie Kneebusch et al.
Mohammad Adam Hamad et al.
Introduction: Urinary tract infections (UTIs) are one of the most common indications for antibiotic use; patients with psychiatric disorders have a greater risk for UTI compared with patients without these disorders. Howe...
Jessica K Burval,Courtney A Iuppa,Carrie R Kriz et al.
Jessica K Burval et al.
Introduction: Objectives of this study were to characterize barriers to receiving psychiatric medications for people who are incarcerated, to compare barriers before competency restoration to those after competency restor...
Jessa Koch
Jessa Koch
Parkinson disease (PD) impacts nearly 1 million individuals in the United States. Nearly every patient with PD will require therapy with dopamine in the form of levodopa as the disease progresses. In more advanced stages of the disease, pat...
Impact of sex on antidepressant discontinuation in groups of similar cytochrome P450 phenotypes [0.03%]
基于相似细胞色素P450表型的抗抑郁药停药受性别影响的研究
Dylan L Kosaski,Kristin C Cole,Jessica A Wright et al.
Dylan L Kosaski et al.
Introduction: Although there are studies assessing reasons for antidepressant discontinuation, little is known about the impact of sex differences or cytochrome P450 phenotypes. Our objective is to assess discontinuation ...